References
- Goodwin JS. Heart disease as the number one cause of death among the elderly. JAMA Intern Med 2014;174:322.
- De Lima JJ, Gowdak LH, de Paula FJ. Diagnosis and treatment of coronary artery disease in hemodialysis patients evaluated for transplant. Transplant Res 2012;1:3.
- Calderon RM, Cubeddu LX, Goldberg RB, Schiff ER. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc 2010;85:349–56.
- Topuz M, Dogan A, Celik A, Can C, Ozdogru I, Kemal Eryol N. Investigation of the relationship between non-alcoholic fatty liver disease and coronary artery disease. Clin Ter 2014;165:e46–51.
- Park BJ, Lee YJ, Lee HR. Chronic liver inflammation: Clinical implications beyond alcoholic liver disease. World J Gastroenterol 2014;20:2168–75.
- Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I, et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 2010;53:713–18.
- Boddi M, Tarquini R, Chiostri M, Marra F, Valente S, Giglioli C, et al. Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes. Eur J Clin Invest 2013;43:429–38.
- Katsi V, Felekos I, Skevofilax S, Aggeli C, Tousoulis D, Stefanadis C, Kallikazaros I. Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship? Cardiol Rev 2015;23:11–17.
- Wong RJ, Kanwal F, Younossi ZM, Ahmed A. Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature. Dig Dis Sci 2014;59:1586–93.
- Huang H, Kang R, Zhao Z. Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis. PLoS One 2014;9:e106376.
- Roberts HW, Utuama OA, Klevens M, Teshale E, Hughes E, Jiles R. The contribution of viral hepatitis to the burden of chronic liver disease in the United States. Am J Gastroenterol 2014;109:387–93.
- Zhao P, Wei Z, Liu W. Is there a straightforward relationship between hepatitis C virus infection and diabetes? Hepatology 2015;61:1097–8.
- Jaumdally RJ, Lip GY, Patel JV, MacFadyen RJ, Varma C. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus. J Intern Med 2009;265:689–97.
- Schillie SF, Xing J, Murphy TV, Hu DJ. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999-2010. J Viral Hepat 2012;19:674–6.
- Abdo AA, Lee SS. Hepatitis C, insulin resistance and fatty liver: bad things come in threes. Can J Gastroenterol 2012;26:323.
- Kcomt W, Nahavandi AA, Myaing M, Alkhalil C, Stein D. Hepatitis C and the heart: to beat or not to beat. Int J Cardiol 2004;96:147–9.
- Wong ND, Patao C, Malik S, Iloeje U. Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine). Am J Cardiol 2014;113:1356–61.
- Khan NA, Daskalopoulou SS, Karp I, Eisenberg MJ, Pelletier R, Tsadok MA, et al. Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med 2013;173:1863–71.
- Widmer RJ, Allison TG, Keane B, Dallas A, Lerman LO, Lerman A, et al. Using an online, personalized program reduces cardiovascular risk factor profiles in a motivated, adherent population of participants. Am Heart J 2014;167:93–100.
- Qureshi N, Armstrong S, Dhiman P, Saukko P, Middlemass J, Evans PH, et al. Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Ann Intern Med 2012;156:253–62.
- Huang YW, Wang TC, Lin SC, Chang HY, Chen DS, Hu JT, et al. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study. Clin Infect Dis 2013;57:1695–702.
- André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschwège E. Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome). Diabetes Metab 2005;31:542–50.
- Mansourian PG, Yoneda M, Krishna Rao M, Martinez FJ, Thomas E, Schiff ER. Effects of statins on the risk of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) 2014;10:417–26.
- Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, et al. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. Hepatology 2014;60:679–86.